Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
Craig F McCabe, Shannon E McCabeMcCabe Vision Center, Murfreesboro, TN, USABackground: The aim of this study was to compare patient-perceived relief of ocular itch, nasal symptoms, and eye drop comfort when allergic conjunctivitis was treated with bepotastine besilate 1.5% versus olopatadine hydroch...
Main Authors: | McCabe CF, McCabe SE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-10-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/comparative-efficacy-of-bepotastine-besilate-15-ophthalmic-solution-ve-a11381 |
Similar Items
-
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
by: Bergmann MT, et al.
Published: (2014-08-01) -
Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis
by: Cavet ME, et al.
Published: (2018-03-01) -
Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
by: Marini MC, et al.
Published: (2023-11-01) -
Efficacy of Bepotastine versus Olopatadine Ophthalmic Solutions in Mild to Moderate Vernal Keratoconjunctivitis as a Sole Therapy
by: Rahul Dara, et al.
Published: (2022-06-01) -
Comparative observational analysis of clinical outcomes in patients of vernal keratoconjunctivitis treated with eye drops olopatadine or bepotastine besilate
by: Preeti Yadav, et al.
Published: (2022-01-01)